FMR CORP 13D and 13G filings for Cyclerion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 09:59 am Purchase |
2023-02-09 | 13G | Cyclerion Therapeutics, Inc. CYCN |
FMR CORP | 171,048 7.865% |
40,178 (+30.70%) |
Filing |
| 2022-02-09 09:11 am Sale |
2022-02-08 | 13G | Cyclerion Therapeutics, Inc. CYCN |
FMR CORP | 130,871 6.042% |
-5,115 (-3.76%) |
Filing |
| 2021-02-08 10:19 am Purchase |
2021-02-05 | 13G | Cyclerion Therapeutics, Inc. CYCN |
FMR CORP | 135,986 8.008% |
9,412 (+7.44%) |
Filing |